Canaccord Genuity

Canopy Growth Corp (NYSE: CGC) announced Wednesday its beverage company partner Constellation Brands, Inc. (NYSE: STZ) is increasing its stake in the company to 38 percent.  The Analyst Canaccord Genuity's Matt Bottomley on Aug. 15 upgraded Canopy Growth from Hold to Speculative Buy...

Dropbox Inc (NASDAQ: DBX) shares moved lower in reaction to second-quarter results that came in better-than-expected but were accompanied by an announcement of Chief Operating Officer Dennis Woodside's departure.  Should investors take advantage of the dip? Four street...

Dropbox Inc (NASDAQ: DBX) apparently disappointed the Street with its second quarterly report as a public company Thursday.  The Analyst Canaccord Genuity analyst Richard Davis maintained a Buy rating on the shares of Dropbox and lifted the price target from $36 to $38....

Sierra Wireless, Inc. (NASDAQ: SWIR) reported its second-quarter results Thursday evening. Earnings per share and sales both beat consensus estimates. The company also issued guidance for the third quarter on the higher end of analysts’ expectations. The Analyst Canaccord Genuity’s T....

Tesla Inc (NASDAQ: TSLA) shares traded up about 15 percent after the firm reported second-quarter earnings, and one analyst sees room for continued upside. The Rating Canaccord Genuity analyst Jed Dorsheimer initiated coverage on Tesla with a Hold rating and a $336 price target. The Thesis...

Casual burger chain Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) delivered a disappointing preliminary second-quarter earnings update Wednesday that prompted Canaccord Genuity to downgrade the stock.  The Analyst Canaccord's Lynne Collier downgraded Red Robin from Buy to...

Prior to a big bounce Wednesday morning, Nevro Corp (NYSE: NVRO) stock was down nearly 50 percent in the past month. Much of the drop came Tuesday following what the market perceived as bad news tied to the company’s patent dispute with Boston Scientific Corporation (NYSE...

Forty Seven Inc. (NASDAQ: FTSV), a clinical-stage immuno-oncology companhy that went public in June, picked up two sell-side bulls Monday.  The Analysts Morgan Stanley analyst Matthew Harrison initiated Forty Seven with an Overweight rating and $25 price target. Canaccord Genuity analyst...

The biotech space represents a gold mine of opportunity for investors to multiply their investment returns, courtesy of the volatility generated by market-moving catalysts. In a note this week, Canaccord Genuity analyst Sumant Kulkarni presented a list of key catalysts for companies in his coverage...

Investors punished eBay Inc (NASDAQ: EBAY) after its second-quarter earnings report and forward looking guidance disappointed many investors. Here's a summary of how five of the Street's top analysts reacted to the print. The Analysts Morgan Stanley's Brian Nowak maintains an...